192 related articles for article (PubMed ID: 1450492)
21. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.
Rudman D; Kutner MH; Chawla RK; Goldsmith MA
J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201
[TBL] [Abstract][Full Text] [Related]
22. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study.
Walter MC; Lochmüller H; Reilich P; Klopstock T; Huber R; Hartard M; Hennig M; Pongratz D; Müller-Felber W
Neurology; 2000 May; 54(9):1848-50. PubMed ID: 10802796
[TBL] [Abstract][Full Text] [Related]
23. Urinary excretion of acid-soluble peptides in children with Duchenne muscular dystrophy.
Hirano K; Sakamoto Y
Acta Paediatr Jpn; 1994 Dec; 36(6):627-31. PubMed ID: 7871971
[TBL] [Abstract][Full Text] [Related]
24. Decreased incidence of Duchenne muscular dystrophy in western Japan 1956-1980.
Takeshita K; Kasagi S; Mito T; Tanaka T; Ootani K
Neuroepidemiology; 1987; 6(3):130-8. PubMed ID: 3658082
[TBL] [Abstract][Full Text] [Related]
25. Clinical trials of vasoactive and antiserotonin drugs in Duchenne muscular dystrophy.
Patten BM; Zeller RS
Ann Clin Res; 1983 Aug; 15(4):164-6. PubMed ID: 6360027
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice.
Komatsu K; Inazuki K; Hosoya J; Satoh S
Exp Neurol; 1986 Jan; 91(1):23-9. PubMed ID: 3940877
[TBL] [Abstract][Full Text] [Related]
28. [Treatment problems using anabolic steroids in progressive muscular dystrophy].
Badalian LO; Temin PA; Mukhin KIu
Klin Med (Mosk); 1984 Nov; 62(11):23-9. PubMed ID: 6394898
[No Abstract] [Full Text] [Related]
29. Allopurinol for muscular dystrophy.
Griffiths JR; Shuttlewood RJ
Lancet; 1980 Aug; 2(8191):423-4. PubMed ID: 6105542
[No Abstract] [Full Text] [Related]
30. Allopurinol ineffective in Duchenne muscular dystrophy.
Bretag AH; Stern LM; Ballard FJ; Tomas FM; Cooper DM; Fewings JD; Goldblatt E
Lancet; 1981 Jan; 1(8214):276. PubMed ID: 6109925
[No Abstract] [Full Text] [Related]
31. Verapamil in Duchenne muscular dystrophy.
Emery AE; Skinner R; Howden LC; Matthews MB
Lancet; 1982 Mar; 1(8271):559. PubMed ID: 6120408
[No Abstract] [Full Text] [Related]
32. Functional evaluation of Duchenne muscular dystrophy: proposal for a protocol.
Cornelio F; Dworzak F; Morandi L; Fedrizzi E; Balestrini MR; Gondoni L
Ital J Neurol Sci; 1982 Dec; 3(4):323-30. PubMed ID: 6762370
[TBL] [Abstract][Full Text] [Related]
33. Child neuromuscular disease in southern Norway. The prevalence and incidence of Duchenne muscular dystrophy.
Tangsrud SE; Halvorsen S
Acta Paediatr Scand; 1989 Jan; 78(1):100-3. PubMed ID: 2784019
[TBL] [Abstract][Full Text] [Related]
34. The elusive promise of myostatin inhibition for muscular dystrophy.
Wagner KR
Curr Opin Neurol; 2020 Oct; 33(5):621-628. PubMed ID: 32773450
[TBL] [Abstract][Full Text] [Related]
35. A double-blind placebo controlled trial of diltiazem in Duchenne dystrophy.
Pernice W; Beckmann R; Ketelsen UP; Frey M; Schmidt-Redemann B; Haap KP; Roehren R; Sauer M
Klin Wochenschr; 1988 Jul; 66(13):565-70. PubMed ID: 2463406
[TBL] [Abstract][Full Text] [Related]
36. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.
Fenichel GM; Florence JM; Pestronk A; Mendell JR; Moxley RT; Griggs RC; Brooke MH; Miller JP; Robison J; King W
Neurology; 1991 Dec; 41(12):1874-7. PubMed ID: 1745340
[TBL] [Abstract][Full Text] [Related]
37. Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy.
Nakahara M; Yamada S
Arzneimittelforschung; 1967 Jun; 17(6):753-6. PubMed ID: 5632380
[No Abstract] [Full Text] [Related]
38. Pharmocologic therapy of dystrophy in man and animals.
Munsat TL
Ann N Y Acad Sci; 1979; 317():400-8. PubMed ID: 289320
[No Abstract] [Full Text] [Related]
39. [Japanese clinical statistical data of patients with progressive muscular dystrophy].
Nakamura K; Arahata K; Satoyoshi E
Nihon Rinsho; 1992 Nov; 50 Suppl():179-85. PubMed ID: 1344347
[No Abstract] [Full Text] [Related]
40. Mazindol and growth hormone inhibition in Duchenne muscular dystrophy.
Zatz M; Vainzof M; Rapaport D; da Rocha JM; Pavanello Rde C; Betti RT
Am J Med Genet; 1987 Aug; 27(4):993-5. PubMed ID: 3321999
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
